1. Home
  2. VERV vs UHT Comparison

VERV vs UHT Comparison

Compare VERV & UHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VERV
  • UHT
  • Stock Information
  • Founded
  • VERV 2018
  • UHT 1986
  • Country
  • VERV United States
  • UHT United States
  • Employees
  • VERV N/A
  • UHT N/A
  • Industry
  • VERV Medicinal Chemicals and Botanical Products
  • UHT Real Estate Investment Trusts
  • Sector
  • VERV Health Care
  • UHT Real Estate
  • Exchange
  • VERV Nasdaq
  • UHT Nasdaq
  • Market Cap
  • VERV 475.0M
  • UHT 496.9M
  • IPO Year
  • VERV 2021
  • UHT N/A
  • Fundamental
  • Price
  • VERV $6.14
  • UHT $37.27
  • Analyst Decision
  • VERV Strong Buy
  • UHT
  • Analyst Count
  • VERV 4
  • UHT 0
  • Target Price
  • VERV $25.75
  • UHT N/A
  • AVG Volume (30 Days)
  • VERV 1.5M
  • UHT 74.7K
  • Earning Date
  • VERV 02-25-2025
  • UHT 02-25-2025
  • Dividend Yield
  • VERV N/A
  • UHT 7.89%
  • EPS Growth
  • VERV N/A
  • UHT 3.98
  • EPS
  • VERV N/A
  • UHT 1.31
  • Revenue
  • VERV $24,396,000.00
  • UHT $99,899,000.00
  • Revenue This Year
  • VERV $97.47
  • UHT N/A
  • Revenue Next Year
  • VERV N/A
  • UHT N/A
  • P/E Ratio
  • VERV N/A
  • UHT $28.45
  • Revenue Growth
  • VERV 219.91
  • UHT 3.43
  • 52 Week Low
  • VERV $4.31
  • UHT $32.27
  • 52 Week High
  • VERV $19.34
  • UHT $47.30
  • Technical
  • Relative Strength Index (RSI)
  • VERV 53.75
  • UHT 47.13
  • Support Level
  • VERV $5.32
  • UHT $34.56
  • Resistance Level
  • VERV $6.87
  • UHT $37.88
  • Average True Range (ATR)
  • VERV 0.52
  • UHT 0.91
  • MACD
  • VERV -0.00
  • UHT 0.27
  • Stochastic Oscillator
  • VERV 56.74
  • UHT 76.99

About VERV Verve Therapeutics Inc.

Verve Therapeutics Inc is a genetic medicines company pioneering a new approach to the care of cardiovascular disease, transforming treatment from chronic management to single-course gene editing medicines. The company's initial two programs target PCSK9 and ANGPTL3, genes that have been extensively validated as targets for lowering blood lipids such as low-density lipoprotein cholesterol, a root cause of cardiovascular disease. The company views its operations as and manages its business in one operating segment operating exclusively in the United States.

About UHT Universal Health Realty Income Trust

Universal Health Realty Income Trust is a healthcare REIT. The company is engaged in the business of investing in and leasing healthcare and human service facilities through direct ownership or through joint ventures, which aggregate into a single reportable segment. The company actively manages a portfolio of healthcare and human service facilities. The revenue and net income are generated from the operation of the investment portfolio which is located throughout the United States.

Share on Social Networks: